From neutron to patient™
Innovative cancer treatment that are just-in-time
Radiopharmaceuticals are sterile injectable radioactive products that are produced on-demand for a specific patient, presenting a unique set of manufacturing complexities.
Welcome to our 80,000 ft² state-of-the-art production facility
The facility is licensed for alpha and beta-emitting isotopes and contains dedicated space for commercial-scale automated packaging. Located at the Crossroads of America in Indianapolis, Indiana, shipments from the facility can reach 50% of the US population within 10 hours by local ground transportation, and to the rest of North America and Western Europe within 48 hours by air.
Patents and proprietary technology
POINT has both developed and licenced an innovative portfolio of best-in-class products, formulation and manufacturing processes. Our world-leading research and development teams are working to change the course of cancer.